- Tarsus Pharmaceuticals is seeking FDA approval in the US and is listed on the Nasdaq stock exchange.
A spokesperson issued a warning regarding issues within the pharmaceutical supply chain.
3 reports, 3 independent
Updated Sep 9
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 3
- Developments
- 2
- Repetition
- 33%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
A spokesperson issued a warning regarding issues within the pharmaceutical supply chain.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Warning issued regarding pharmaceutical supply chain issues.1 source
Hadi Ahmadi warned of future shortages in materials needed for pharmaceutical production due to the US/Israel war.1 source
Keep exploring
The entities involved
-
Hadi Ahmadi
Artist from Iran
Nothing else this week.